Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-06 · accession 0001773751-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-07 | 2025-01-06 | HIMS | Boughton Soleil | CLO | S - Sale+OE | $27.75 | -268.9K | 169.8K | -61% | -$7.46M |
| DM | 2025-01-07 | 2025-01-06 | HIMS | Boughton Soleil | CLO | M - OptEx | $3.85 | +254.0K | 298.5K | +571% | +$979.1K |
| DM | 2025-01-07 | 2025-01-06 | HIMS | Boughton Soleil | CLO | M - OptEx | $0.00 | -254.0K | 694.2K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-06 | S | D | 238,932 | $27.72 | 199,803 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-01-06 | M | A | 140,255 | $5.01 | 438,735 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-01-06 | M | A | 113,768 | $2.43 | 298,480 | D | — | — | |
| 4 | Common | Class A Common Stock | 2025-01-06 | S | D | 30,000 | $28.00 | 169,803 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2025-01-06 | M | D | 113,768 | $0.00 | 0 | D | $2.43 · — to 2030-05-12 | 113,768 Class A Common Stock | (F2) The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous Service beginning February 12, 2020. |
| 6 | Derivative | Stock Option (right to buy) | 2025-01-06 | M | D | 140,255 | $0.00 | 694,154 | D | $5.01 · — to 2032-02-23 | 140,255 Class A Common Stock | (F3) The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer. |